Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
NYS Entity Status
NYS Filing Date
SEPTEMBER 17, 2014
NYS DOS ID#
CT CORPORATION SYSTEM
111 EIGHTH AVENUE
NEW YORK, NEW YORK, 10011
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - ICAP MERGER COMPANY LLC
Around the Web
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
- Shareholders Demand More Drastic Shifts at Nestlé
By STEPHANIE STROM - Tuesday Jun 27, 2017
The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.
- Worldpay Group, a British Payments Processor, Fields Two Possible Takeover Bids
By CHAD BRAY - Tuesday Jul 4, 2017
The company said that it had been contacted by Vantiv, a rival payments company based in Cincinnati, and by the banking powerhouse JPMorgan Chase.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- Rooted in Counterculture, Whole Foods’ Founder Finds an Unlikely Refuge
By MICHAEL J. de la MERCED and ALEXANDRA STEVENSON - Friday Jun 16, 2017
John Mackey wanted to fight off the activist investors attacking Whole Foods. He found a savior in Amazon, a company blamed for laying waste to retailers.